Accession Number: | 0001061983-21-000109 |
Date: | 2021-04-09 |
Issuer: | CYTOKINETICS INC (CYTK) |
Original Submission Date: |
SMITH SANDFORD D
280 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA 94080
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-04-09 | M | 3,207 | a | $6.82 | 4,127 | direct | ||
COMMON STOCK | 2021-04-09 | S | 3,207 | d | $24.00 | 920 | direct | ||
COMMON STOCK | 2021-04-09 | M | 5,000 | a | $7.61 | 5,920 | direct | ||
COMMON STOCK | 2021-04-09 | S | 5,000 | d | $23.79 | 920 | direct | ||
COMMON STOCK | 2021-04-09 | M | 5,000 | a | $7.61 | 5,920 | direct | ||
COMMON STOCK | 2021-04-09 | S | 5,000 | d | $23.80 | 920 | direct | ||
COMMON STOCK | 2021-04-09 | M | 5,000 | a | $7.61 | 5,920 | direct | ||
COMMON STOCK | 2021-04-09 | S | 5,000 | d | $23.79 | 920 | direct | ||
COMMON STOCK | 2021-04-09 | M | 5,000 | a | $7.61 | 5,920 | direct | ||
COMMON STOCK | 2021-04-09 | S | 5,000 | d | $23.79 | 920 | direct | ||
COMMON STOCK | 2021-04-09 | M | 4,375 | a | $10.00 | 5,295 | direct | ||
COMMON STOCK | 2021-04-09 | S | 4,375 | d | $24.50 | 920 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) | 6.82 | 2021-04-09 | deemed execution date | M | 3,207 (d) | 2019-02-01 | 2029-01-02 | common stock 3,207 | $6.82 | 0 | direct | |
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) | 7.61 | 2021-04-09 | deemed execution date | M | 5,000 (d) | 2016-06-18 | 2026-05-18 | common stock 5,000 | $7.61 | 15,000 | direct | |
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) | 7.61 | 2021-04-09 | deemed execution date | M | 5,000 (d) | 2016-06-18 | 2026-05-18 | common stock 5,000 | $7.61 | 10,000 | direct | |
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) | 7.61 | 2021-04-09 | deemed execution date | M | 5,000 (d) | 2016-06-18 | 2026-05-18 | common stock 5,000 | $7.61 | 5,000 | direct | |
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) | 7.61 | 2021-04-09 | deemed execution date | M | 5,000 (d) | 2016-06-18 | 2026-05-18 | common stock 5,000 | $7.61 | 0 | direct | |
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) | 10.0 | 2021-04-09 | deemed execution date | M | 4,375 (d) | 2016-02-04 | 2026-01-04 | common stock 4,375 | $10.00 | 0 | direct |
ID | footnote |
---|---|
f1 | transaction effected pursuant to a 10b5-1 plan entered into by the reporting person on march 10, 2021. |
f2 | amount includes 920 shares of common stock received at reporting person's election pursuant issuer's stock in lieu of cash for all or part of directors' annual base retainer program. |